Senti Biosciences is trading at $0.43 (+6.49%) following a low-liquidity technical rebound in after-hours trading.
- No fresh company-specific catalysts or major announcements were identified to justify the price action.
- Recent coverage suggests the move is primarily driven by thin liquidity and technical factors rather than fundamental earnings news.